ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol
; 29(Suppl 3): 616-617, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35930113
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
Language:
En
Year:
2022
Type:
Article